IPC MT Instituto de Pesquisas Clinicas do Mato Grosso

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)2 trials

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Biogen2 trials

Running trials

• Active, not recruiting

  A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

  NCT05531565· Phase 2/3· Biogen· Source

• Enrolling by invitation

  A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)

  NCT05352919· Phase 3· Biogen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting